Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity (Q43675214)

25 November 2017

Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity (English)

1 reference

25 November 2017

1 reference

Carroll R

1

1 reference

PubMed ID

11454595

25 November 2017

Severson DL

series ordinal

2

1 reference

25 November 2017

1 August 2001

1 reference

American Journal of Physiology Heart and Circulatory Physiology

25 November 2017

1 reference

25 November 2017

281

1 reference

25 November 2017

H888-94

1 reference

25 November 2017

2

1 reference

PPARgamma, the ultimate thrifty gene

25 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Forms of lipoprotein lipase in rat tissues: in adipose tissue the proportion of inactive lipase increases on fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Peroxisome proliferator-activated receptors in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Regulation of the synthesis, processing and translocation of lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Lipoprotein lipase activity in rat cardiomyocytes is stimulated by insulin and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Differential expression and activation of a family of murine peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Orphan nuclear receptors: shifting endocrinology into reverse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Fatty acid homeostasis in the normoxic and ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

Lipotoxic heart disease in obese rats: implications for human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.2001.281.2.H888

10.1152/AJPHEART.2001.281.2.H888

21 January 2018

Identifiers

DOI

0 references

PubMed ID

11454595

1 reference

PubMed ID

11454595